The Society for Immunotherapy of Cancer (SITC) received over 1,300 abstract submissions in 2025, and has announced titles and authors for the accepted Late-breaking Abstracts (LBA). Late-breaking ...
A Chicago man whose 16-year-old daughter is undergoing treatment for advanced cancer will be released on bond and return home ...
Phase 2 clinical trial underway with first patient dosed in October to support a clear path to Phase 3 based on previous alignment with FDA Patients randomized to either 10 or 20 mg/kg of muzastotug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback